Elite in HIV/AIDS

Cecile C. Goujard

Université Paris Est Créteil, 
Creteil, FR 
Elite in HIV/AIDS
Université Paris Est Créteil, 
Creteil, FR 
OverviewLocationsClinical Research

Overview

Cecile Goujard practices in Creteil, France. Ms. Goujard is rated as an Elite expert by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Mixed Connective Tissue Disease, Hepatitis, and Anton Syndrome.

Her clinical research consists of co-authoring 167 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 95 articles and participated in 1 clinical trial in the study of HIV/AIDS.

Gender
Female

Locations

Université Paris Est Créteil, Creteil, France
Other Locations
Paris, France
Kremlin Bicêtre, France
Fontenay-sous-bois, 92265, France
Rennes, 35033, France
Villejuif, 94807, France
Fresnes-sur-marne, France
Orsay, France
Saint-aubin-les-forges, France
Nantes, 44093, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') or or Authorisation for Early Access (AAP). A Prospective Cohort.
Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') or or Authorisation for Early Access (AAP). A Prospective Cohort.
Enrollment Status: Completed
Publish Date: May 28, 2025
Intervention Type: Other
A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: June 04, 2024
Intervention Type: Drug
Study Drugs: Cabotegravir, Rilpivirine, BIKTARVY
Study Phase: Phase 3
Study Among People Living With HIV and Their Health Professionals of Associated Factors of Resilience to Self-stigma
Study Among People Living With HIV and Their Health Professionals of Associated Factors of Resilience to Self-stigma
Enrollment Status: Completed
Publish Date: May 01, 2023
Evaluation of a Shared Health Information System for Home-hospital Management of Febrile NEUTROpenia After Cytotoxic Chemotherapy
Evaluation of a Shared Health Information System for Home-hospital Management of Febrile NEUTROpenia After Cytotoxic Chemotherapy
Enrollment Status: Completed
Publish Date: May 09, 2022
Intervention Type: Device
Study Phase: Not Applicable
View 3 Less Clinical Trials

167 Total Publications

Higher plasma concentrations of von Willebrand factor in women than in men during both the acute and chronic phases of HIV infection.
Higher plasma concentrations of von Willebrand factor in women than in men during both the acute and chronic phases of HIV infection.
Journal: AIDS (London, England)
Published: February 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Goujard's expertise for a condition
ConditionClose
    View All 26 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile